Myriad Genetics (MYGN) Earnings Date & Reports

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individualâ€™s risk of developing a disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MYGN is expected to report earnings to fall 286.33% to -5 cents per share on May 01

Myriad Genetics MYGN Stock Earnings Reports

Q1'25

Est.

$-0.06

Q4'24

Est.

$0.03

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.06

Q1'24

Beat

by $0.09

The last earnings report on February 24 showed earnings per share of 2 cents, meeting the estimate of 2 cents. With 819.60K shares outstanding, the current market capitalization sits at 1.93B.

View a ticker or compare two or three

Compare

MYGN